Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, comments on the use of cabozantinib and vandetinib in medullary thyroid cancer.
Eric J. Sherman, MD
Articles by Eric J. Sherman, MD
Latest Updated Articles
Using Cabozantinib and Vandetanib in Medullary Thyroid CancerPublished: May 16th 2013 | Updated: